@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix go: . @prefix Protein: . @prefix pfh: . @prefix geneProductOf: . @prefix hasAgent: . @prefix sdis: . @prefix species: . @prefix occursIn: . @prefix mesh: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 hasAgent: sub:_2; a go:0042789 . sub:_2 geneProductOf: pfh:NOTCH%20Family; a Protein: . sub:_3 occursIn: mesh:D002467, mesh:D004727, species:9606; rdf:object sdis:tumor%20angiogenesis; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "tscript(p(PFH:\"NOTCH Family\")) -> path(SDIS:\"tumor angiogenesis\")" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_5; pav:version "1.4" . sub:_4 prov:value "The Notch signaling from the tumor cells is able to activate endothelial cells and thus initiate tumor angiogenesis. Accordingly, the neovasculature is able to stimulate the tumor growth and progression."; prov:wasQuotedFrom pubmed:16023591 . sub:_5 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:16023591; prov:wasDerivedFrom beldoc:, sub:_4 . } sub:pubinfo { this: dct:created "2014-07-03T14:30:36.869+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }